These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2215268)

  • 21. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
    Masuda Y; Hirao T; Mizunuma H
    J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen substitution therapy in climacteric: should progesterone be omitted in hysterectomized women?].
    Huber J
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):257-61. PubMed ID: 1860657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
    Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
    Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1992 Dec; 15(3):171-81. PubMed ID: 1465031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin viscoelasticity during hormone replacement therapy for climacteric ageing.
    Piérard GE; Hermanns-Lê T; Paquet P; Piérard-Franchimont C
    Int J Cosmet Sci; 2014 Feb; 36(1):88-92. PubMed ID: 24152248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone replacement therapy (HRT) in peri- and postmenopause. Is it also allowed after treatment of breast carcinoma?].
    Graf H; Retzke U
    Zentralbl Chir; 1998; 123 Suppl 5():151-5. PubMed ID: 10063602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of hormone replacement therapy by menopausal women: a comparison between primary care patients and the general population.
    Nakhlé AR; Galobardes B; Humair JP; Stalder H
    Soz Praventivmed; 2005; 50(4):238-44. PubMed ID: 16167508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
    Saver BG; Taylor TR; Woods NF
    J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of the effect of hormone replacement therapy upon depressed mood.
    Zweifel JE; O'Brien WH
    Psychoneuroendocrinology; 1997 Apr; 22(3):189-212. PubMed ID: 9203229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The climacteric in The Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy.
    Barentsen R
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S7-11. PubMed ID: 8732466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormone replacement therapy: curse or blessing?].
    Schmidt M; Fink D; Lang U; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):442-8. PubMed ID: 9197447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.